News
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's ...
Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.
Computational research in fruit flies revealed how spontaneously arising genes are tightly controlled, offering insights into ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...
Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...
18h
TipRanks on MSNMixed options sentiment in Novo Nordisk with shares down 1.4%
Mixed options sentiment in Novo Nordisk (NVO), with shares down 72c near $50.19. Options volume relatively light with 36k contracts traded and ...
Two leading cardiology groups have joined forces to position heart failure as a preventable condition, encouraging clinicians ...
Three stocks that fall into that category today include Lululemon Athletica (NASDAQ: LULU), Novo Nordisk (NYSE: NVO), and ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
The FDA’s De Novo authorization for the tool establishes a new product code category for future AI-powered digital pathology risk-stratification tools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results